Evidence map›Paper›PMID 37975236›Full record

ArticlePharmacogenomics2023

Pharmacogenomics implementation across multiple clinic settings: a qualitative evaluation.

Sarah A Shue, Elizabeth Rowe, Lauren A Bell, Teresa Damush, Alexis DeLong, Tayler Gowan, Todd Skaar, David Haggstrom

Abstract read
In one paragraph

Article in Pharmacogenomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah A ShueVA HSR&D Center for Health Information & Communication, Roudebush VA Medical Center, Indianapolis, IN 46202, USA.ORCID 0000-0003-3944-5923
Elizabeth RoweDivision of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0001-5978-0695
Lauren A BellDivision of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0001-6677-4517
Teresa DamushVA HSR&D Center for Health Information & Communication, Roudebush VA Medical Center, Indianapolis, IN 46202, USA.
Alexis DeLongCenter for Health Services Research, Regenstrief Institute, Indianapolis, IN 46202, USA.
Tayler GowanCenter for Health Services Research, Regenstrief Institute, Indianapolis, IN 46202, USA.
Todd SkaarDivision of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
David HaggstromVA HSR&D Center for Health Information & Communication, Roudebush VA Medical Center, Indianapolis, IN 46202, USA.

Funding

Indiana University Comprehensive Training in Clinical PharmacologyT32GM008425 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Zeruesenay Desta, Michael Thomas Eadon · 1992 to 2026
$7.7M
Damush HSR&D Research Career Scientist Award ApplicationIK6HX002715 · VA · RLR VA MEDICAL CENTER · PI DAMUSH, TERESA M. · 2020 to 2024
–
HSRD VA IK6 HX002715NIGMS NIH HHS T32 GM008425
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Delivery of Health CarePharmacogeneticsHumansadoptionbarriersCFIRfacilitatorspharmacogenetic testing

Identifiers

PMID37975236
PMCPMC12510241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.